Amarpreet Sandhu
Nephrology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · Sutter Davis Hospital · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Amarpreet Sandhu’s office to ask if they take your plan before you enroll.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Sutter Davis HospitalDavis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Davis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 1 the same, 0 worse of 2 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 247 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.43 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.9 · 94 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 857 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,791 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,822 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (0.68 to 5.75) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.4) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.351 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 169 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13 · 94 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 123 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.6 to 16.4) · 878 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 240 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 82% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$98,204
Medicare paid this office $98,204 for 353 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $39,464 | $106 |
| Long return visit (40+ min) | 229 | $35,864 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $9,849 | $154 |
| Long return visit (40+ min) | 54 | $8,090 | $144 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 142 | $2,351 | $15 |
See all 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $39,464 | $106 |
| Long return visit (40+ min) | 229 | $35,864 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $9,849 | $154 |
| Long return visit (40+ min) | 54 | $8,090 | $144 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 142 | $2,351 | $15 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,149 | $77 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 27 | $372 | $13 |
Who their Medicare patients are
353 Original Medicare patients in 2024. Average age 61 · Under 65 50% · Women 44% · Also on Medicaid 55% · Health risk score 5.43. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 63% · Coronary heart disease 47% · Heart failure 34% · Depression 24% · Atrial fibrillation 23% · COPD 12% · Cancer 8% · Stroke 6% · Dementia 4%.
The office billed $382,767, Medicare allowed $128,121 and paid $98,204; for 1,009 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 353 | 1,009 | 61 | 5.43 | $382,767 | $98,204 |
| 2023 | 319 | 685 | 59 | 5.10 | $309,991 | $83,550 |
| 2022 | 350 | 726 | 60 | 4.64 | $315,443 | $85,184 |
| 2021 | 344 | 758 | 61 | 5.01 | $321,107 | $92,045 |
| 2020 | 372 | 754 | 59 | 4.85 | $344,378 | $76,905 |
| 2019 | 377 | 710 | 60 | 5.05 | $341,495 | $77,777 |
| 2018 | 415 | 825 | 60 | 4.99 | $361,894 | $80,517 |
| 2017 | 404 | 972 | 59 | 4.39 | $409,947 | $92,326 |
| 2016 | 457 | 946 | 59 | 4.78 | $413,201 | $95,507 |
| 2015 | 424 | 895 | 59 | 4.77 | $386,252 | $92,043 |
| 2014 | 136 | 305 | 57 | 6.02 | $132,399 | $31,127 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $31,864 | $108 |
| Long return visit (40+ min) | 173 | $26,426 | $120 |
| Long return visit (40+ min) | 66 | $10,869 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,165 | $158 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,152 | $82 |
2022: 5 services
| Long return visit (40+ min) | 159 | $26,771 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $25,940 | $92 |
| Long return visit (40+ min) | 129 | $18,865 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,991 | $180 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,246 | $89 |
2021: 5 services
| Long return visit (40+ min) | 168 | $30,603 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $27,907 | $94 |
| Long return visit (40+ min) | 125 | $20,303 | $150 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $10,181 | $182 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,157 | $105 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $32,301 | $96 |
| Long return visit (40+ min) | 154 | $17,748 | $98 |
| Long return visit (40+ min) | 126 | $12,932 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $9,793 | $181 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,286 | $92 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,018 | $73 |
2019: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $27,141 | $94 |
| Long return visit (40+ min) | 116 | $15,398 | $115 |
| Long return visit (40+ min) | 118 | $13,145 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,748 | $176 |
| New patient visit (60+ min) | 36 | $5,557 | $154 |
| New patient visit (60+ min) | 12 | $1,816 | $151 |
| Return visit (30+ min) | 20 | $1,740 | $87 |
| Extended office or other outpatient service, first hour | 14 | $1,607 | $107 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 116 | $33,423 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $10,734 | $168 |
| Return visit (30+ min) | 95 | $8,245 | $79 |
| Long return visit (40+ min) | 81 | $8,082 | $94 |
| Long return visit (40+ min) | 51 | $5,795 | $111 |
| Return visit (30+ min) | 61 | $4,210 | $66 |
| New patient visit (60+ min) | 24 | $4,077 | $170 |
| New patient visit (60+ min) | 24 | $3,398 | $142 |
| Extended office or other outpatient service, first hour | 14 | $1,426 | $102 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $43,021 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,685 | $175 |
| Long return visit (40+ min) | 91 | $10,817 | $95 |
| Return visit (30+ min) | 90 | $7,342 | $81 |
| Long return visit (40+ min) | 58 | $6,452 | $108 |
| Return visit (30+ min) | 65 | $4,535 | $65 |
| Extended office or other outpatient service, first hour | 15 | $1,781 | $105 |
| Short return visit (20+ min) | 22 | $1,145 | $50 |
| Short return visit (20+ min) | 22 | $988 | $41 |
2016: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 115 | $41,270 | $93 |
| Long return visit (40+ min) | 119 | $14,912 | $117 |
| Long return visit (40+ min) | 122 | $12,631 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,703 | $181 |
| Return visit (30+ min) | 58 | $4,770 | $79 |
| New patient visit (60+ min) | 26 | $3,954 | $152 |
| Return visit (30+ min) | 43 | $2,826 | $59 |
| New patient visit (60+ min) | 15 | $2,545 | $170 |
| Extended office or other outpatient service, first hour | 12 | $1,021 | $85 |
| Short return visit (20+ min) | 12 | $523 | $44 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 113 | $38,389 | $94 |
| Long return visit (40+ min) | 136 | $18,726 | $121 |
| Long return visit (40+ min) | 104 | $11,287 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $9,106 | $182 |
| Return visit (30+ min) | 71 | $6,267 | $86 |
| New patient visit (60+ min) | 22 | $3,150 | $143 |
| Return visit (30+ min) | 30 | $2,171 | $70 |
2014: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $16,151 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,517 | $181 |
| Long return visit (40+ min) | 37 | $3,989 | $97 |
| Long return visit (40+ min) | 13 | $1,615 | $124 |
| Return visit (30+ min) | 15 | $1,054 | $70 |
Medicaid work
$19,145 in 2024
Medicaid paid $19,145 for 417 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 206 | $9,903 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 196 | $7,935 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 15 | $1,307 |
| 2024 | 417 | 3 | 27 | $19,145 |
| 2023 | 279 | 2 | 38 | $15,113 |
| 2022 | 282 | 3 | 42 | $12,600 |
| 2021 | 242 | 2 | 29 | $11,602 |
| 2020 | 258 | 2 | 37 | $9,045 |
| 2019 | 105 | 2 | 16 | $5,442 |
| 2018 | 50 | 2 | 14 | $3,561 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 210 | $9,315 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 69 | $5,798 |
2022
| Long return visit (40+ min) | 228 | $10,527 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 42 | $1,690 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 12 | $383 |
2021
| Long return visit (40+ min) | 200 | $9,531 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 42 | $2,070 |
2020
| Long return visit (40+ min) | 203 | $7,021 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 55 | $2,024 |
2019
| Long return visit (40+ min) | 72 | $3,435 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $2,008 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 37 | $2,208 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 13 | $1,353 |
Drugs they prescribed that Part D paid
$269,757
Pharmacies billed $269,757 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 986) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
878 generic and 91 brand-name prescriptions · $269,757 in drug cost · 92 antibiotic prescriptions to 56 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Everolimus | 23 | $39,555 | $1,720 |
| Vemlidy | 19 | $31,233 | $1,644 |
| Cinacalcet | 27 | $20,302 | $752 |
| Tacrolimus | 74 | $14,572 | $197 |
| Lokelma | 14 | $11,217 | $801 |
See all 20 drugs
| Everolimus | 23 | $39,555 | $1,720 |
| Vemlidy | 19 | $31,233 | $1,644 |
| Cinacalcet | 27 | $20,302 | $752 |
| Tacrolimus | 74 | $14,572 | $197 |
| Lokelma | 14 | $11,217 | $801 |
| Valganciclovir | 55 | $7,682 | $140 |
| Mycophenolate Mofetil | 57 | $3,825 | $67 |
| Clotrimazole | 14 | $2,796 | $200 |
| Prednisone | 277 | $1,453 | $5 |
| Nano 2nd Gen Pen Needle | 17 | $984 | $58 |
| Sulfamethoxazole-Trimethoprim | 50 | $271 | $5 |
| Losartan | 35 | $270 | $8 |
| Pantoprazole | 50 | $262 | $5 |
| Fluconazole | 11 | $165 | $15 |
| Tamsulosin | 13 | $110 | $8 |
| Carvedilol | 16 | $95 | $6 |
| Metoprolol | 22 | $76 | $3 |
| Ciprofloxacin | 17 | $58 | $3 |
| Amlodipine Besylate | 15 | $57 | $4 |
| Atorvastatin | 15 | $34 | $2 |
Year by year
| 2024 | 986 | 246 | 0% (0) | 9% | $269,757 |
| 2023 | 1,054 | 246 | 0% (0) | 5% | $154,127 |
| 2022 | 1,048 | 229 | 0% (0) | 4% | $155,647 |
| 2021 | 1,450 | 307 | 0% (0) | 3% | $170,138 |
| 2020 | 1,932 | 335 | 0% (0) | 3% | $212,792 |
| 2019 | 1,475 | 301 | None | 7% | $196,779 |
| 2018 | 1,285 | 212 | None | 9% | $191,574 |
| 2017 | 1,306 | 158 | 2% (25) | 11% | $354,412 |
| 2016 | 1,234 | 139 | 1% (16) | 11% | $195,051 |
| 2015 | 1,029 | 100 | 2% (21) | 14% | $162,340 |
| 2014 | 175 | 36 | None | None | $50,337 |
| 2013 | 187 | 44 | 0% (0) | 21% | $13,408 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Tacrolimus | 134 | $34,191 | $255 |
| Everolimus | 12 | $24,484 | $2,040 |
| Cinacalcet | 24 | $19,156 | $798 |
| Valganciclovir | 42 | $9,057 | $216 |
| Mycophenolate Mofetil | 116 | $8,076 | $70 |
| Clotrimazole | 23 | $4,971 | $216 |
| Sirolimus | 11 | $3,559 | $324 |
| Prednisone | 304 | $2,232 | $7 |
| Nano 2nd Gen Pen Needle | 17 | $1,007 | $59 |
| Tamsulosin | 21 | $678 | $32 |
| Pantoprazole | 44 | $547 | $12 |
| Carvedilol | 26 | $503 | $19 |
| Sulfamethoxazole-Trimethoprim | 47 | $458 | $10 |
| Hydralazine | 17 | $408 | $24 |
| Amlodipine Besylate | 27 | $323 | $12 |
| Losartan | 17 | $320 | $19 |
| Metoprolol | 15 | $160 | $11 |
| Furosemide | 16 | $153 | $10 |
| Cephalexin | 14 | $144 | $10 |
| Ciprofloxacin | 15 | $55 | $4 |
2022: 21 drugs
| Tacrolimus | 144 | $34,734 | $241 |
| Cinacalcet | 31 | $25,745 | $830 |
| Valganciclovir | 64 | $19,610 | $306 |
| Everolimus | 14 | $13,642 | $974 |
| Mycophenolate Mofetil | 99 | $8,768 | $89 |
| Mycophenolic Acid | 16 | $8,492 | $531 |
| Eliquis | 11 | $6,287 | $572 |
| Clotrimazole | 28 | $4,857 | $173 |
| Prednisone | 247 | $1,730 | $7 |
| Nano 2nd Gen Pen Needle | 18 | $1,025 | $57 |
| Azathioprine | 12 | $523 | $44 |
| Pantoprazole | 47 | $513 | $11 |
| Sulfamethoxazole-Trimethoprim | 58 | $456 | $8 |
| Hydralazine | 16 | $294 | $18 |
| Metoprolol | 25 | $226 | $9 |
| Amlodipine Besylate | 25 | $190 | $8 |
| Losartan | 16 | $182 | $11 |
| Carvedilol | 12 | $99 | $8 |
| Omeprazole | 12 | $72 | $6 |
| Furosemide | 12 | $71 | $6 |
| Cephalexin | 15 | $63 | $4 |
2021: 26 drugs
| Cinacalcet | 36 | $29,131 | $809 |
| Tacrolimus | 122 | $24,490 | $201 |
| Valganciclovir | 70 | $21,205 | $303 |
| Everolimus | 12 | $17,840 | $1,487 |
| Mycophenolate Mofetil | 113 | $7,070 | $63 |
| Mycophenolic Acid | 14 | $6,933 | $495 |
| Clotrimazole | 35 | $4,822 | $138 |
| Prednisone | 231 | $1,852 | $8 |
| Entecavir | 12 | $1,416 | $118 |
| Hydralazine | 47 | $848 | $18 |
| Calcitriol | 11 | $723 | $66 |
| Pantoprazole | 68 | $677 | $10 |
| Metoprolol | 92 | $635 | $7 |
| Carvedilol | 71 | $605 | $9 |
| Rosuvastatin | 12 | $563 | $47 |
| Sulfamethoxazole-Trimethoprim | 75 | $559 | $7 |
| Tamsulosin | 47 | $507 | $11 |
| Amlodipine Besylate | 105 | $460 | $4 |
| Acyclovir | 12 | $212 | $18 |
| Bethanechol Chloride | 11 | $197 | $18 |
| Atorvastatin | 17 | $169 | $10 |
| Metoprolol | 14 | $156 | $11 |
| Ciprofloxacin | 20 | $136 | $7 |
| Losartan | 15 | $108 | $7 |
| Furosemide | 19 | $93 | $5 |
| Hydrochlorothiazide | 12 | $45 | $4 |
2020: 28 drugs
| Cinacalcet | 47 | $60,555 | $1,288 |
| Tacrolimus | 183 | $38,229 | $209 |
| Valganciclovir | 74 | $27,741 | $375 |
| Mycophenolic Acid | 22 | $14,340 | $652 |
| Veltassa | 13 | $13,629 | $1,048 |
| Mycophenolate Mofetil | 124 | $9,077 | $73 |
| Clotrimazole | 28 | $6,119 | $219 |
| Prednisone | 320 | $2,309 | $7 |
| Pantoprazole | 87 | $1,096 | $13 |
| Calcitriol | 25 | $1,040 | $42 |
| Nifedipine Er | 29 | $826 | $28 |
| Hydralazine | 49 | $819 | $17 |
| Bethanechol Chloride | 13 | $784 | $60 |
| Metoprolol | 128 | $753 | $6 |
| Tamsulosin | 80 | $729 | $9 |
| Carvedilol | 101 | $663 | $7 |
| Rosuvastatin | 14 | $621 | $44 |
| Amlodipine Besylate | 118 | $621 | $5 |
| Entecavir | 13 | $501 | $39 |
| Sulfamethoxazole-Trimethoprim | 64 | $410 | $6 |
| Atorvastatin | 34 | $295 | $9 |
| Losartan | 42 | $286 | $7 |
| Metoprolol | 21 | $253 | $12 |
| Ciprofloxacin | 26 | $168 | $6 |
| Clonidine | 22 | $142 | $6 |
| Gabapentin | 11 | $112 | $10 |
| Furosemide | 15 | $65 | $4 |
| Simvastatin | 11 | $50 | $5 |
2019: 30 drugs
| Sensipar | 20 | $37,546 | $1,877 |
| Cinacalcet | 36 | $32,712 | $909 |
| Veltassa | 19 | $18,934 | $997 |
| Tacrolimus | 95 | $18,912 | $199 |
| Valganciclovir | 44 | $16,220 | $369 |
| Clotrimazole | 29 | $4,934 | $170 |
| Mycophenolate Mofetil | 68 | $4,767 | $70 |
| Entecavir | 13 | $2,095 | $161 |
| Prednisone | 150 | $1,405 | $9 |
| Bethanechol Chloride | 18 | $1,063 | $59 |
| Comfort Ez Pen Needle | 13 | $986 | $76 |
| Amlodipine Besylate | 166 | $981 | $6 |
| Nitrofurantoin | 15 | $872 | $58 |
| Pantoprazole | 59 | $839 | $14 |
| Calcitriol | 34 | $747 | $22 |
| Metoprolol | 118 | $616 | $5 |
| Carvedilol | 64 | $588 | $9 |
| Tamsulosin | 41 | $574 | $14 |
| Hydralazine | 38 | $469 | $12 |
| Rosuvastatin | 16 | $428 | $27 |
| Metoprolol | 16 | $357 | $22 |
| Atorvastatin | 48 | $355 | $7 |
| Isosorbide Mononitrate Er | 17 | $235 | $14 |
| Clonidine | 23 | $229 | $10 |
| Omeprazole | 11 | $226 | $21 |
| Losartan | 35 | $216 | $6 |
| Sulfamethoxazole-Trimethoprim | 38 | $212 | $6 |
| Ciprofloxacin | 17 | $138 | $8 |
| Furosemide | 21 | $117 | $6 |
| Losartan-Hydrochlorothiazide | 13 | $57 | $4 |
2018: 26 drugs
| Sensipar | 24 | $53,098 | $2,212 |
| Valganciclovir | 38 | $32,556 | $857 |
| Tacrolimus | 37 | $9,686 | $262 |
| Humalog Kwikpen U-100 | 13 | $7,225 | $556 |
| Mycophenolate Mofetil | 30 | $4,875 | $162 |
| Januvia | 11 | $4,794 | $436 |
| Clotrimazole | 37 | $3,046 | $82 |
| Prednisone | 131 | $1,111 | $8 |
| Tamsulosin | 59 | $1,013 | $17 |
| Isosorbide Dinitrate | 11 | $979 | $89 |
| Atorvastatin | 75 | $803 | $11 |
| Nifedipine Er | 26 | $788 | $30 |
| Pantoprazole | 57 | $662 | $12 |
| Calcitriol | 12 | $656 | $55 |
| Metoprolol | 117 | $641 | $5 |
| Hydralazine | 47 | $518 | $11 |
| Amlodipine Besylate | 102 | $441 | $4 |
| Azathioprine | 11 | $440 | $40 |
| Omeprazole | 13 | $384 | $30 |
| Carvedilol | 59 | $287 | $5 |
| Sulfamethoxazole-Trimethoprim | 38 | $247 | $6 |
| Unifine Pentips | 12 | $230 | $19 |
| Clonidine | 28 | $172 | $6 |
| Furosemide | 49 | $122 | $2 |
| Lisinopril | 23 | $107 | $5 |
| Ciprofloxacin | 12 | $63 | $5 |
2017: 25 drugs
| Valganciclovir | 86 | $148,308 | $1,725 |
| Sensipar | 33 | $76,641 | $2,322 |
| Humalog Kwikpen U-100 | 26 | $14,072 | $541 |
| Lantus Solostar | 22 | $8,658 | $394 |
| Novolog Flexpen | 16 | $8,468 | $529 |
| Clotrimazole | 51 | $8,066 | $158 |
| Mycophenolate Mofetil | 30 | $2,590 | $86 |
| Tacrolimus | 17 | $1,555 | $91 |
| Tamsulosin | 67 | $1,241 | $19 |
| Nifedipine Er | 30 | $930 | $31 |
| Pantoprazole | 94 | $826 | $9 |
| Unifine Pentips | 36 | $766 | $21 |
| Metoprolol | 100 | $551 | $6 |
| Atorvastatin | 75 | $548 | $7 |
| Prednisone | 50 | $488 | $10 |
| Pen Needles | 25 | $486 | $19 |
| Hydralazine | 38 | $372 | $10 |
| Amlodipine Besylate | 87 | $316 | $4 |
| Clonidine | 35 | $313 | $9 |
| Sulfamethoxazole-Trimethoprim | 53 | $291 | $5 |
| Carvedilol | 47 | $164 | $3 |
| Hydrocodone-Acetaminophen | 18 | $142 | $8 |
| Ciprofloxacin | 19 | $112 | $6 |
| Lisinopril | 25 | $96 | $4 |
| Furosemide | 26 | $84 | $3 |
2016: 34 drugs
| Valganciclovir | 54 | $68,860 | $1,275 |
| Sensipar | 24 | $44,129 | $1,839 |
| Lantus Solostar | 27 | $10,185 | $377 |
| Novolog Flexpen | 19 | $9,233 | $486 |
| Humalog Kwikpen U-100 | 16 | $8,876 | $555 |
| Mycophenolate Mofetil | 46 | $7,323 | $159 |
| Nexium | 16 | $6,144 | $384 |
| Clotrimazole | 40 | $5,419 | $135 |
| Tacrolimus | 43 | $5,282 | $123 |
| Humalog | 12 | $3,705 | $309 |
| Pantoprazole | 117 | $1,417 | $12 |
| Prednisone | 83 | $819 | $10 |
| Unifine Pentips | 28 | $735 | $26 |
| Calcitriol | 17 | $627 | $37 |
| Tamsulosin | 30 | $615 | $20 |
| Amlodipine Besylate | 81 | $529 | $7 |
| Atorvastatin | 72 | $515 | $7 |
| Hydralazine | 49 | $445 | $9 |
| Nifedipine Er | 15 | $407 | $27 |
| Labetalol | 11 | $370 | $34 |
| Nitrofurantoin | 14 | $342 | $24 |
| Clonidine | 29 | $275 | $9 |
| Sulfamethoxazole-Trimethoprim | 48 | $273 | $6 |
| Pen Needles | 16 | $267 | $17 |
| Metoprolol | 46 | $221 | $5 |
| Clopidogrel | 11 | $180 | $16 |
| Omeprazole | 24 | $156 | $7 |
| Ciprofloxacin | 18 | $148 | $8 |
| Hydrocodone-Acetaminophen | 12 | $135 | $11 |
| Carvedilol | 25 | $123 | $5 |
| Cephalexin | 12 | $99 | $8 |
| Lisinopril | 12 | $88 | $7 |
| Furosemide | 15 | $79 | $5 |
| Metoclopramide | 14 | $77 | $6 |
2015: 30 drugs
| Valganciclovir | 37 | $57,359 | $1,550 |
| Sensipar | 13 | $22,954 | $1,766 |
| Humalog Kwikpen U-100 | 23 | $10,756 | $468 |
| Nexium | 21 | $6,640 | $316 |
| Novolog Flexpen | 11 | $4,866 | $442 |
| Clotrimazole | 35 | $4,385 | $125 |
| Lantus Solostar | 11 | $4,166 | $379 |
| Novolog | 11 | $2,428 | $221 |
| Pantoprazole | 121 | $1,325 | $11 |
| Labetalol | 24 | $1,240 | $52 |
| Tamsulosin | 43 | $1,132 | $26 |
| Calcitriol | 23 | $819 | $36 |
| Atorvastatin | 69 | $586 | $8 |
| Prednisone | 42 | $466 | $11 |
| Hydralazine | 25 | $456 | $18 |
| Amlodipine Besylate | 68 | $357 | $5 |
| Sulfamethoxazole-Trimethoprim | 36 | $302 | $8 |
| Metoprolol | 55 | $276 | $5 |
| Pen Needles | 13 | $219 | $17 |
| Insulin | 12 | $214 | $18 |
| Hydrocodone-Acetaminophen | 16 | $185 | $12 |
| Carvedilol | 26 | $174 | $7 |
| Clonidine | 19 | $171 | $9 |
| Omeprazole | 14 | $167 | $12 |
| Lisinopril | 19 | $153 | $8 |
| Clopidogrel | 12 | $127 | $11 |
| Minoxidil | 11 | $110 | $10 |
| Metoclopramide | 14 | $98 | $7 |
| Furosemide | 20 | $94 | $5 |
| Glipizide | 14 | $36 | $3 |
2014: 3 drugs
| Clotrimazole | 13 | $2,077 | $160 |
| Pantoprazole | 12 | $84 | $7 |
| Metoprolol | 11 | $56 | $5 |
2013: 5 drugs
| Tamsulosin | 45 | $1,984 | $44 |
| Hydralazine | 17 | $449 | $26 |
| Furosemide | 35 | $196 | $6 |
| Amlodipine Besylate | 18 | $122 | $7 |
| Lisinopril | 13 | $75 | $6 |
Money from drug and device companies
$23 in 2025
| 2025 | 1 | 1 | None | $23 |
| 2024 | 1 | 1 | None | $18 |
| 2023 | 1 | 1 | None | $122 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Zerbaxa | $23 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Meals · 2025-02-28 | Zerbaxa | $23 |
See earlier years (2024, 2023)
2024: $18
| Merck Sharp & Dohme | Prevymis | $18 | 1 payment
|
2023: $122
| Sanofi-Aventis U.S. | None | $122 | 1 payment
|
Professional record
- NPI
- 1912226002
- Licence
- CA 20A 11150
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 4986 Cherry Ave, San Jose, CA, 95118
- NPI first listed
- 2010-05-28
- NPI last updated
- 2014-07-25
This is when the NPI record was last certified, not a medical board exam.